Clinical Trial Update: Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve Patients [NA]

View source ↗

Summary

Completed clinical trial update reporting pharmacokinetics, pharmacodynamics, and safety data for DEB025 (alisporivir) in combination with ribavirin in treatmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Debio-025 (alisporivir) (alisporivir)
• Ribavirin (ribavirin)

Snippet

Sponsor: Debiopharm International SA | Conditions: Hepatitis C, Liver Disease | NA | Status: COMPLETED